SAM Medical, a developer and manufacturer of trauma care medical devices, has launched the SAM IO Intraosseous Access System for pre-hospital and hospital healthcare providers in the civilian and military sectors.
“Designed to be an effective and intuitive alternative solution to intraosseous access, the SAM IO’s unique manually powered and multi-use driver offers medical professionals the ability to quickly and easily administer critical fluids and medications into a patient’s vascular system through the bone marrow during emergency situations,” the company stated.
The SAM IO is comprised of two main components: a driver and a needle assembly. The needle assembly, including a catheter and stylet, is secured to the driver via a snap-fit design. The needle is then introduced through the soft tissue of either the proximal humerus, proximal tibia, distal tibia, or distal femur (pediatrics only). Once the needle tip is in contact with bone, the driver handle is actuated, producing rotational control of the needle assembly. The cutting flutes of the catheter drill through cortical bone until the needle assembly is introduced into the bone marrow. The driver and stylet are then removed from the catheter.
The SAM IO system is designed to be intuitive for current IO users, featuring colour-coding and depth indicators that match industry norms.
The SAM IO Intraosseous Access System has received FDA clearance and is now available in the U.S. and will be broadening to worldwide markets in the near future. With the global risks of the Coronavirus, the company is also initiating a remote training format for the SAM IO. For more information, contact Denise Ehlert at 503-783-6923 or at denise.ehlert@sammedical.com.
For more than 30 years, SAM Medical has developed and manufactured medical products used by military, law enforcement, emergency, wilderness and sports medicine, and pre-hospital care around the world.
Print this page
